Intel is in a powerful but violently volatile uptrend that has recently rolled over: the stock is up 127.88% over the past year and 120.82% year-to-date, yet at $86.96 it sits only about 49.4% of the way through its 52-week range of $32.89 to $142.35, roughly 39% below the high. That positioning is unusual for a stock with such a large annual gain — it signals the rally peaked near $142 in late September and has since given back a substantial portion, leaving the stock in a corrective phase rather than at momentum highs. The 41.9% maximum drawdown confirms this is a high-beta name where trend-following entries near highs have repeatedly been punished. Recent momentum is decisively negative and diverging sharply from the longer-term trend: the stock is down 29.07% over the past month and 5.81% over three months, versus a 1-year gain of 127.88%, producing a relative-strength reading of -28.05 versus the S&P 500 over one month. The 3-month relative strength of -8.66 and 6-month of -1.10 show the outperformance is fading fast, and the last two weeks alone saw the price fall from $120.23 on September 30 to $86.96, including a drop from $92.96 to $85.49 on October 22. This looks like a momentum unwind and mean-reversion event rather than a simple pullback, with the 1.72% bounce on the final day insufficient to reverse the damage. Key levels are clear: support sits at the 52-week low of $32.89, with intermediate support around the July/August lows near $81.88-$86.30 that are now being tested, while resistance is the 52-week high of $142.35 and the $120-$127 shelf that capped the September rally. A breakdown below the $81.88 area would confirm a deeper trend reversal toward the mid-$70s, whereas reclaiming $100-$105 would signal stabilization. With a beta of 2.23, Intel is more than twice as volatile as the market, meaning position sizing must account for roughly 2.2x the index's swings — a critical risk-management consideration given the 41.9% drawdown and 71.8 million share volume.

Revenue is reaccelerating impressively even as profitability lags: the most recent quarter (ended June 27, 2026) delivered $16.128 billion in revenue, up 25.42% year-over-year from $12.859 billion, continuing a sequence of $13.577 billion in Q1 2026, $13.674 billion in Q4 2025, and $13.653 billion in Q3 2025. Segment data shows the growth engine is diversified — CCPG (client computing) at $8.877 billion, DCAI (data center) at $6.262 billion, and Intel Foundry at $5.765 billion, with $5.477 billion of intersegment eliminations — indicating the data center and foundry businesses are now material contributors rather than peripheral. The trajectory from $12.667 billion in Q1 2025 to $16.128 billion in Q2 2026 represents roughly 27% growth over five quarters, supporting the bull case that Intel's product cycle and foundry ramp are translating into top-line acceleration. Profitability remains the weak link: Q2 2026 net income was -$11.033 billion with a -68.4% net margin, driven largely by a $12.8 billion non-operating charge (total other income/expenses of -$12.8 billion), while operating income was actually positive at $1.981 billion (12.28% operating margin) and gross margin was 41.51%. Gross margin has improved from 27.54% in Q2 2025 to 39.38% in Q1 2026 and 41.51% in Q2 2026, a clear expansion trend, but the trailing net margin of -0.51% and operating margin of -4.19% in the valuation data show the company is not yet sustainably profitable. The gap between positive operating income and deeply negative net income underscores that below-the-line items, not core operations, are driving losses — a distinction that matters for assessing the durability of any earnings recovery. The balance sheet is a relative bright spot: debt-to-equity is a modest 0.408, the current ratio is 2.017, and cash stood at $13.597 billion at the end of Q2 2026, while free cash flow turned positive at $4.45 billion in that quarter (TTM FCF of $2.831 billion) after -$2.54 billion in Q1 2026. However, capital expenditure remains heavy at $2.556 billion in Q2 and $3.636 billion in Q1, and the company has been reliant on external financing — $4.096 billion of common stock issued in Q4 2025 and $427 million in Q1 2026 — while paying down $5.5 billion of debt in Q2. ROE of -0.23% and ROA of 1.41% confirm capital returns are barely positive, and the $14.339 billion of dividends paid in Q2 (per cash flow) alongside a 0% stated dividend yield suggests a one-time or special distribution rather than recurring income.